Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137878 · ClinicalTrials.gov registry record · Phase 2
TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer
A Phase 2 study, sponsored by GenVec.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00137878: Completed Phase 2 study, sponsored by GenVec.
NCT00137878 is a Phase 2 study that has completed, run by GenVec. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00137878, a Phase 2 study, has completed, sponsored by GenVec.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine if the addition of TNFerade™ to pre-operative chemoradiotherapy increases the number of pathologic complete responses when compared to pre-operative chemoradiotherapy alone as assessed following complete surgical resection of primary rectal cancer.
Interventions
- DRUG TNFerade™
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 2 |
What the finished NCT00137878 record still lists
NCT00137878 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which TNFerade™ is the first listed.
NCT00137878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00137878 about?
NCT00137878 is a clinical study titled "TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer". The purpose of this study is to determine if the addition of TNFerade™ to pre-operative chemoradiotherapy increases the number of pathologic complete responses when compared to pre-operative chemoradiotherapy alone as assessed following complete surgical resection of primary rectal cancer.
What is the current status of trial NCT00137878?
This trial is currently completed. It is a Phase 2 study.
What interventions are being tested in trial NCT00137878?
The interventions under investigation include: TNFerade™ (DRUG).
Who is sponsoring clinical trial NCT00137878?
This trial is sponsored by GenVec, which has 7 total clinical trials registered on ClinicalTrials.gov.